MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on April 29, 2008; DOI: 10.1124/mol.108.046623


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.046623v1
74/2/348    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dickinson, J. A
Right arrow Articles by Wonnacott, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dickinson, J. A
Right arrow Articles by Wonnacott, S.


Received for publication February 25, 2008.
Revised April 28, 2008.
Accepted for publication April 28, 2008.

Presynaptic {alpha}7 and {beta}2-containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms

Jane A Dickinson 1, James N. C. Kew 2, Susan Wonnacott 1*

1 University of Bath 2 GlaxoSmithKline

* Address correspondence to: E-mail: s.wonnacott{at}bath.ac.uk

Abstract

Nicotine can enhance working memory and attention. Activation of both {alpha}7 and {beta}2* nicotinic acetylcholine receptors (nAChRs) in the prefrontal cortex (PFC) has been implicated in these processes. The ability of presynaptic nAChRs to modulate neurotransmitter release, notably glutamate release, is postulated to contribute to nicotine's effects. We have examined the cellular mechanisms underlying {alpha}7 and {beta}2* nAChR-mediated [3H]D-aspartate release from the PFC in vitro. Using the {alpha}7 and {beta}2* nAChR selective agonists compound A and 5-iodo-A-85380, respectively, in conjunction with inhibitors of voltage-operated Ca2+ channels (VOCC) and intracellular Ca2+ stores, we show that [3H]D-aspartate release evoked by activation of {beta}2* nAChRs occurs via VOCCs. In contrast, {alpha}7 nAChR-evoked release was unaffected by VOCC blockers but was abolished by modulators of Ca2+ stores, including ryanodine. The {alpha}7 nAChR ligand {alpha}-bungarotoxin and ryanodine receptors were colocalised to a subpopulation of PFC synaptosomes. Compound A-evoked [3H]D-aspartate release was also blocked by MEK1 inhibitors, implicating ERK1/2 in {alpha}7 nAChR-evoked exocytosis. Western blotting confirmed that compound A, but not 5-iodo-A-85380, application increased ERK2 phosphorylation in PFC synaptosomes and this was dependent on ryanodine-sensitive stores. Compound A also promoted synapsin-1 phosphorylation at ERK1/2-dependent sites, in a ryanodine-sensitive manner. Thus {beta}2* and {alpha}7 nAChR subtypes in the PFC mediate [3H]D-aspartate release via distinct mechanisms as a result of their differential coupling to VOCCs and Ca2+-induced Ca2+ release (CICR), respectively. The ability of {alpha}7 nAChRs to promote the phosphorylation of presynaptic ERK2 and synapsin-1, downstream of CICR, provides a potential mechanism for presynaptic facilitation in the PFC.


Key words: Nicotinic cholinergic, MAP Kinase, Immunocytochemistry, Exocytosis





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics